For more than a decade, Johnson & Johnson has been a key partner of SOS Children’s Villages. The impact of this global partnership has been far-reaching, spanning many countries and multiple programmes.
As we look to the future, it is clear that the world is undergoing a tremendous demographic shift. In a number of countries, young people under the age of 24 will soon make up the majority of the population. Many of them will reach adulthood in countries with little to no social protection or employment opportunities.
This is what makes our partnership invaluable. Johnson & Johnson and the Johnson & Johnson Corporate Citizenship Trust (Trust) are supporting the full spectrum of care - from family foundations; access to critical education and vocational training and capacity strengthening for communities and caregivers, for instance through the nursing scholarship programme in Sub-Saharan Africa – all supporting those on the front lines of delivering care.
In 2015, Janssen, the pharmaceutical division of Johnson & Johnson, became a healthcare partner of SOS Children’s Villages. They have provided support to the caregivers who work with children who have lost, or are at risk of losing parental care with the ambition to empower social change, especially for vulnerable young people. An example of the kind of support provided by Janssen is the “Grow Happily” project in the Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania and Russia, which aims to address the early childhood development delays of children in need in the SOS Children’s Villages programmes.
Through the Secondment Program of the Johnson & Johnson Corporate Citizenship Trust, the skills and talents of Johnson & Johnson global employees are also being leveraged to strengthen the daily work of SOS Children’s Villages.
Find out more about the programme in this video